Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering

American Journal of Hypertension

Volumn 7, Issue 10, 1991, Pages 886-893

  Egan, Brent M ^a   Stepniakowski, Konrad ^a   Goodfriend, Theodore L ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

Abdominal obesity; Aldosterone; Hyperinsulinemia; Renin; Salt restriction

Indexed keywords

ALDOSTERONE; INSULIN; RENIN;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; CLUSTER ANALYSIS; CORONARY ARTERY DISEASE; DIET; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; HYPERTENSION; MALE; METABOLISM; OBESITY; PATHOPHYSIOLOGY; RISK FACTOR; SODIUM INTAKE; SODIUM RESTRICTION; BORDERLINE HYPERTENSION; CLINICAL ARTICLE; CONTROLLED STUDY; HYPERINSULINEMIA; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; ALDOSTERONE; ANTHROPOMETRY; BLOOD PRESSURE; CLUSTER ANALYSIS; CORONARY DISEASE; DIET; DIET, SODIUM-RESTRICTED; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; HYPERTENSION; INSULIN; MALE; OBESITY; RENIN; RISK FACTORS; SODIUM, DIETARY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028020777     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/7.10.886     Document Type: Article

References (37)

1. Prebble WE: Obesity: observations on one thousand cases. Boston Medical and Surgical J 1923;88:617-621.
2. Vague J: The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956;4:20-34.
3. Kissebah AH, Vydelingum N, Murray R, et al: Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metabol 1982;54: 254-260.
4. Peiris AN, Sothmann MS, Hoffmann RG, et al: Adi-posity, fat distribution, and cardiovascular risk. Ann Intern Med 1989;110:867-872.
5. Lapidus L, Bengtsson C, Larsson B, et al: Distribution of adipose tissue and risk of cardiovascular disease and death: a 12-year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J 1984;289:1257-1261.
6. Stokes J, Garrison RJ, Kännel WB: The independent contributions of various indices of obesity to the 22- year incidence of coronary heart disease: the Framingham Heart Study. Proceedings of the International Symposium on the Metabolic Complications of Human Obesities, Marseilles, France. May 30-June 1, 1985. Amsterdam, Elsevier, 1986.
7. Pyörälä K: Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979;2:131-141.
8. Welborn TA, Wearne K: Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979;2:154-160.
9. Meade TW, Cooper JA, Peart WS: Plasma renin activity and ischemic heart disease. N Engl J Med 1993;329: 616-619.
10. Brunner HR, Laragh JH, Baer L, et al: Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med 1972;286:441-449.
11. Alderman MH, Madhavan S, Ooi WL, et al: Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991;324:1098-1104.
12. Trovati M, Massucco P, Anfossi G, et al: Insulin influences the renin-angiotensin-aldosterone system in humans. Metabolism 1989;38:501-503.
13. Petrasek D, Jensen G, Tuck M, Stern N: In vitro effects of insulin on aldosterone production in rat zona glom- erulosa cells. Life Sei 1992;50:1781-1787.
14. Weinsier RL, Norris DJ, Birch R, et al: The relative contribution of body fat and fat pattern to blood pressure level. Hypertension 1985;7:578-585.
15. Tuck ML, Sowers J, Dornfeld L, et al: The effect of weight reduction on blood pressure, plasma renin activity and plasma aldosterone levels in obese patients. N Engl J Med 1981;304:930-933.
16. Sowers JR, Nyby M, Stern N, et al: Blood pressure and hormone changes associated with weight reduction in the obese. Hypertension 1982;4:686-691.
17. Marks P, Wilson B, Delassalle A: Aldosterone studies in obese patients with hypertension. Am J Med Sei 1985;289:224-228.
18. Rocchini AP, Katch VL, Grekin R, et al: Role of aldosterone in blood pressure regulation of obese adolescents. Am J Cardiol 1986;57:613-618.
19. Lind L, Lithell H, Wide L, Ljunghall S: Metabolic cardiovascular risk factors and the renin-aldosterone system in essential hypertension. J Hum Hypertens 1992; 6:27-29.
20. Iwaoka T, Umeda T, Ohno M, et al: The effect of low and high NaCl diets on oral glucose tolerance. Klin Wochenschr 1988;66:724-728.
21. Egan BM, Stepniakowski K: Effects of enalapril on the hyperinsulinémie response to severe salt restriction in obese young men with mild systemic hypertension. Am J Cardiol 1993;72:5S-57.
22. Sharma AM, Ruland K, Spies K-P, Distler A: Salt sensitivity in young normotensive subjects is associated with a hyperinsulinemia response to oral glucose. J Hypertens 1991;9:329-335.
23. Donovan DS, Solomon CG, Seely EW, et al: Effect of sodium intake on insulin sensitivity. Am J Physiol 1993;264:E730-E734.
24. Alderman MH, Lamport B: Moderate sodium restriction: do the benefits justify the hazards? Am J Hypertens 1990;3:499-504.
25. Weder AB, Egan BM: Potential deleterious impact of dietary salt restriction on cardiovascular risk factors. Klin Wochenschr 1991;69(suppl 15):45-50.
26. Kaplan NM: The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989;149:1514-1520.
27. Egan BM, Stepniakowski K, Nazzaro P: Insulin levels are similar in obese salt-sensitive and salt-resistant hypertensive subjects. Hypertension 1994;23(suppl 1):11-17.
28. Neahring JM, Stepniakowski K, Greene AS, Egan BM: Insulin does not reduce forearm a-vasoreactivity in obese hypertensive or lean normotensive men. Hypertension 1993;22:584-590.
29. Rocchini AP, Moorehead C, DeRemer S, et al: Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II. Hypertension 1990;15:861-866.
30. Goodfriend TL, Ball DL, Weinberger MH, et al: Salt loads raise plasma fatty acids and lower insulin. Hypertension 1991;17:958-964.
31. Durnin JV, Womersley J: Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974;32:77-97.
32. Lohman TG, Roche AF, Martorell R: Anthropometric Standardization Reference Manual. Champaign, IL, Human Kinetics Books, 1988.
33. Bonora E, Moghetti P, Zancanaro C, et al: Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 1989; 68:374-378.
34. Jaffa AA, Chai KX, Chao J, et al: Effects of diabetes and insulin on expression of kallikrein and renin genes in the kidney. Kid Int 1992;41:789-795.
35. Chen Y-DI, Golay A, Swislocki ALM, Reaven GM: Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1987;64:17-21.
36. Randle PJ, Garland PB, Hales CN, Newsholme EA: The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1:785-789.
37. Longworth DL, Drayer JIM, Weber MA, Laragh JH: Divergent blood pressure responses during shortterm sodium restriction in hypertension. Clin Pharmacol Ther 1980;27:454-546.